Cargando…
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Parkinson’s Disease (PD) is characterized both by the loss of dopaminergic neurons in the substantia nigra and the presence of cytoplasmic inclusions called Lewy Bodies. These Lewy Bodies contain the aggregated α-synuclein (α-syn) protein, which has been shown to be able to propagate from cell to ce...
Autores principales: | Teil, Margaux, Arotcarena, Marie-Laure, Faggiani, Emilie, Laferriere, Florent, Bezard, Erwan, Dehay, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175302/ https://www.ncbi.nlm.nih.gov/pubmed/32138193 http://dx.doi.org/10.3390/biom10030391 |
Ejemplares similares
-
Monitoring α-synuclein aggregation
por: Estaun-Panzano, Juan, et al.
Publicado: (2023) -
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019) -
A New Rise of Non-Human Primate Models of Synucleinopathies
por: Teil, Margaux, et al.
Publicado: (2021) -
Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
por: Laferrière, Florent, et al.
Publicado: (2020) -
Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death
por: Bourdenx, Mathieu, et al.
Publicado: (2014)